Semaxanib

Delta-Net Stockinette, Synthetic, 2 x 25yd, Black, Non-Sterile, 2/cs";MPN=7272301"

For updated SDS information please visit www.goodfellow.

InformationCB-103 CB-103 is an orally active inhibitor of the Notch transcription activation complex. CB-103 produces Notch loss-of-function phenotypes in flies and mice and inhibits the growth of human breast cancer and leukemia

Biochem/physiol Actions Originally published as a selective ataxia telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) kinase inhibitor, which causes reversible reprogramming of cellular lifespan, conferred robust growth to senescent cells

General description Glioblastomas are among the most aggressive forms of cancer, associated with low treatment efficacy and poor survival. Recurring glioblastomas are often resistant to first-line chemotherapies (1).

Dimethyl diselenide is a volatile selenium species and its determination in biological samples by HPLC-inductively coupled argon plasma mass spectrometry was reported.Selenium alkylation with dimethyl diselenide was reported by solid-phase

Dimethyl diselenide is a volatile selenium species and its determination in biological samples by HPLC-inductively coupled argon plasma mass spectrometry was reported.Selenium alkylation with dimethyl diselenide was reported by solid-phase

Dimethyl diselenide is a volatile selenium species and its determination in biological samples by HPLC-inductively coupled argon plasma mass spectrometry was reported.Selenium alkylation with dimethyl diselenide was reported by solid-phase

Dimethyl diselenide is a volatile selenium species and its determination in biological samples by HPLC-inductively coupled argon plasma mass spectrometry was reported.Selenium alkylation with dimethyl diselenide was reported by solid-phase

Dimethyl diselenide is a volatile selenium species and its determination in biological samples by HPLC-inductively coupled argon plasma mass spectrometry was reported.Selenium alkylation with dimethyl diselenide was reported by solid-phase

Cell Line Origin Human Caucasian lung small cell carcinoma, metastasis to bone marrow Cell Line Description DMS 92 was obtained from a bone marrow aspirate of an untreated 39 year old male at time of diagnosis. The isolated cells were identified as

InformationDS-1001b (DS 1001) DS-1001b is an oral selective inhibitor of mutant IDH1 R132X with potential antineoplastic activity and is designed to penetrate the blood-brain barrier.TargetsIDH1 R132XIn vitroDS-1001b impairs the proliferation of